Cargando…
Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid
Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian neoplasms. We also aimed to verify whether modern...
Autores principales: | Kozłowski, Mateusz, Nowak, Katarzyna, Kordek, Agnieszka, Cymbaluk-Płoska, Aneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345663/ https://www.ncbi.nlm.nih.gov/pubmed/34360112 http://dx.doi.org/10.3390/ijerph18157819 |
Ejemplares similares
-
Long-Term Follow-Up of a Female Patient Treated with Olaparib—Hope for a Long Life without Relapse?
por: Kozłowski, Mateusz, et al.
Publicado: (2021) -
The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022) -
Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract—Comparison of the Risk Factors and Non-Surgical Treatment Efficacy
por: Lorenz, Anna, et al.
Publicado: (2023) -
Cutaneous Melanoma versus Vulvovaginal Melanoma—Risk Factors, Pathogenesis and Comparison of Immunotherapy Efficacy
por: Lorenz, Anna, et al.
Publicado: (2022) -
Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021)